GlobalTrader

All posts are opinion only and Not investment advice!

[GlobalTrader @GlobalTraderOTC]

@SmallCapBob2 Pump it!!

[AlertsAndNews @AlertsAndNews]

$SBEV 8k here

"Eentered into a Development and Collaboration Agreement (the “Collaboration Agreement”) with Lupvindol Biosciences Ltd."

[Noah Mitchell @NoahMitchellF6]

$SBFM

This tiny-cap biotech stock has yet to attract the attention of most traders.

Sunshine Biopharma has formed a clear bottom after a sharp drop to a solid support level around $1.10. With very few shares outstanding, the stock has significant upside potential once trading volume picks up.

The company has received approval in Canada for its generic version of Dienogest, a treatment for endometriosis, giving it access to a multi-billion dollar global market. The technicals are perfect – bottoming out with low float typically doesn't last long.

Don't miss the breakout opportunity. The first major resistance level is around $1.85; a volume-driven breakout above this level will clear the way to $3 and above. Manage your risk and avoid chasing the price.

#LowCapStocks #BiotechTrading #SmallCap #StockMarket

[StocksDaily @IntradayRider]

$SBFM Sunshine Biopharma gets Canadian approval for generic Dienogest, entering a $2.8B global market
— Generic/specialty pharma sector, women's health expansion
— Dienogest is the generic version of Visanne, a first-line therapy for endometriosis-related pelvic pain
— Global Dienogest market pegged at $2.8B in 2025, projected to hit $5.2B by 2034 at a 7.8% CAGR
— Distributed through wholly owned Canadian subsidiary Nora Pharma, expected to ship to pharmacies by end of 2026
— Company now has 60 generic drugs on the Canadian market with about 12 more planned for the rest of 2026
Not financial advice.

[frankyboyz @frankyboyz]

1.19 given $SBFM printing 1.50 the easy money with no stress... im too old to take panic trades puahahahah

[Chris Jeon @cjeon111]

bought more $OPEN today before earnings

[Shin | $OPENARMY 🇺🇸 🇨🇦 🇰🇷 @mudirshin]

@InversorNovato_ $OPEN I won’t miss this one.

[Jason Z @JasonZX]

Opendoor将在8月4日盘后公布业绩，会计主管站在CEO Kaz身边，一身绿色，配合的很好，希望 $OPEN 股价也能配合，哈哈哈。

[The Long Ape @TheLongApe]

$OPEN Added 2,000 more shares🫡

[Nugget @Nugget_Trades]

CCP says, BUY $OPEN.

[Nexus @GMN_watch]

🚨 $OPEN reports Q2 tomorrow after market close.

Management’s outlook:

• ~25% QoQ revenue growth
• Contribution margin near the midpoint of 5–7%
• Adjusted EBITDA around breakeven
• 12-month forward Adjusted EBITDA profitability beginning in Q2

Financial Open House livestream and shareholder Q&A at 5:00 PM ET.

[Oliver @dawsonhoffman24]

The core narrative for $OPEN is shifting:
It is moving beyond being merely a "home buying and selling company" and aiming to become AI- and data-driven infrastructure for real estate transactions.
A rebound in home acquisitions, improved inventory efficiency, and the anticipation of a profitability inflection point are driving renewed market focus on the company's long-term value.

[Stock Catcher @MorningMadness4]

$GXAI GXAI Gaxos Announces $1,000,000 Share Repurchase Plan

[AlertsAndNews @AlertsAndNews]

$GXAI some hits on this.

Gaxos Announces $1,000,000 Share Repurchase Plan

[Shahram 𐭠𐭩𐭫𐭠𐭭 𐎃 𐎗🩸ꕥ ❈ @BehdinEran]

Hero of Iran.

[GlobalTrader @GlobalTraderOTC]

@stockplaymaker1 $VIVK

[EricTAcoustic @AcousticStocks]

$VIVK

could be a very scrumptious day Monday starting 0400 EST

Will we see $10+

Low down here …..

[KEN @Tatted__Ken]

$VIVK $STAK

Buy now or chase Monday when they’re up 40%.

Your choice.

[TheBull @TheBull_Stocks]

$VBIO being accumulated! 🧐 now could same $FMFC action!

4 million float! 1/2 $FMFC float! SSR
and could get squeezy!

[GlobalTrader @GlobalTraderOTC]

@alkhalifahMoham The dump is over $20 to $2 in a week. Dilution or shorts? I say dilution after rs